NEW YORK, NY, Major Medical Devices, an emerging innovator in vascular intervention technologies with a highly differentiated, potentially quick to market device in a $3 billion market, announces strategic funding.
Major Medical Devices, an emerging innovator in vascular intervention technologies with a highly differentiated, potentially quick to market device in a $3 billion market, announces strategic funding partnership with TCA Venture Group (TCA), a leading investment group based in southern California. The partnership will accelerate development and commercialization of the company's breakthrough abdominal aortic aneurysm (AAA) repair device.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
